INDOLE-3-CARBINOL AND EPIGALLOCATECHIN-3-GALLATE IN COMBINATION THERAPY OF OVARIAN CANCER

被引：0
|
作者：
Ashrafyan, L. A. [1 ]
Antonova, I. B. [1 ]
Aleshikova, O. I. [1 ]
Gerfanova, E. V. [1 ]
机构：
[1] Russian Sci Ctr Roentgenoradiol, Oncogynecol, Moscow, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0560
引用
收藏
页码：432 / 432
页数：1
相关论文
共 50 条
  • [1] Indole-3-carbinol and prostate cancer
    Sarkar, FH
    Li, YW
    JOURNAL OF NUTRITION, 2004, 134 (12): : 3493S - 3498S
  • [2] Combination treatment with epigallocatechin-3-gallate and sulforaphane sensitize ovarian cancer cells to cisplatin
    Chen, Huaping
    Landen, Charles N.
    Alvarez, Ronald D.
    Li, Yuanyuan
    Tollefsbo, Trygve O.
    CANCER RESEARCH, 2012, 72
  • [3] Indole-3-carbinol
    不详
    ALTERNATIVE MEDICINE REVIEW, 2005, 10 (04) : 337 - 342
  • [4] INDOLE-3-CARBINOL
    PREOBRAZHENSKAYA, MN
    KOROLEV, AM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15): : 1210 - 1211
  • [5] INDOLE-3-CARBINOL : A BOON TO CANCER PATIENT
    Srivastav, Bhawana
    Saxena, Vijay L.
    EVERYMANS SCIENCE, 2012, 47 (02): : 122 - 125
  • [6] Targets for indole-3-carbinol in cancer prevention
    Kim, YS
    Milner, JA
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2005, 16 (02): : 65 - 73
  • [7] Synthesis of Indole-3-carbinol
    Jiangsu Xuzhou Vocational College of Pharmaceutics, Xuzhou 221116, China
    Xiandai Huagong/Modern Chemical Industry, 2008, 28 (06): : 43 - 45
  • [8] INDOLE-3-CARBINOL - RESPONSE
    MICHNOVICZ, JJ
    BRADLOW, HL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15): : 1211 - 1212
  • [9] Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment
    B Taylor-Harding
    H Agadjanian
    H Nassanian
    S Kwon
    X Guo
    C Miller
    B Y Karlan
    S Orsulic
    C S Walsh
    British Journal of Cancer, 2012, 106 : 333 - 343
  • [10] Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment
    Taylor-Harding, B.
    Agadjanian, H.
    Nassanian, H.
    Kwon, S.
    Guo, X.
    Miller, C.
    Karlan, B. Y.
    Orsulic, S.
    Walsh, C. S.
    BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 333 - 343
12345